Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the President's Cancer Panel.
The meeting will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as amended because the premature disclosure of information and the discussions would likely to significantly frustrate implementation of recommendations.
Name of Committee: President's Cancer Panel.
Date: September 16, 2002.
Closed: 2 p.m. to 6 p.m.
Agenda: Meeting with Panel, two of which are new Members, to review the previous year's activities of the Panel and develop agendas for future meetings in 2003. These discussions will include confidential NCI operational information, i.e. budget formulations, personnel actions and contract issuances.
Place: National Institutes of Health, 31 Center Drive, Building 31, Room 31/11A10, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Maureen O. Wilson, Ph.D., Executive Secretary, National Cancer Institute, NIH, 31 Center Drive, Building 31, Room 3A18, Bethesda, MD 20892, (301) 496-1148.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institute's/Center's home page: deainfo.nci.nih.gov/advisory/pcp/pcp.htm, where an agenda and any additional information for the meeting will be posted when available.Start Signature
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; Start Printed Page 5541193.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Dated: August 22, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-22067 Filed 8-28-02; 8:45 am]
BILLING CODE 4140-01-M